Recent

% | $
Quotes you view appear here for quick access.

Yahoo! Inc. Message Board

whippersnapper65 1277 posts  |  Last Activity: 8 hours ago Member since: Jun 20, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • August 6, 2014 w/cc pre-announced on July 18
    August 6, 2013 no cc, no pre-announcement
    August 10, 2012 w/cc pre-announced on August 2
    August 3, 2011 w/cc pre-announced on July 25
    August 4, 2010 w/cc pre-announced on July 29
    August 5, 2009 w/cc pre-announced on July 30

    That's as far back as records go on Celldex's website.

    Celldex management has released 2Q earnings within the first week of August in five of the past six years.

    The only year not to have a CC accompany 2Q earnings was 2013, which was also the year that the expansion of ReACT was announced only six days following the earnings release: August 12, 2013 and also announced without a CC.

    Today, August 3, has passed the latest date in August on which the company has previously pre-announced when 2Q earnings and CC would happen.

    But we still have not passed the latest date on which earnings were released previously; that was in 2012 on August 10. There was nothing noteworthy about that release or CC that would have been the reason why management waited until that late date to release earnings.

    I'd speculate that if there is no pre-announcement about the date of earnings release and a CC by the end of this week then something is up. Such a delay would suspiciously deviate from past history.

    Sentiment: Strong Buy

  • Will this be the floor?

    Four months of mostly relentless bleeding in the share price, 1%-3% at a time, is taking its toll on my patience. So is Marucci's silence.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Aug 3, 2015 1:08 AM Flag

    The evidence and the rationale for approving Rintega are overwhelming, not only beyond reasonable doubt: beyond all moral doubt. There is moral certainty that Rintega is effective and should be approved. Any further delay in bringing Rintega to market is a breach of the FDA's responsibility toward Americans who would benefit from Rintega's efficacy.

    So, what's the holdup? Let's get this done!

    Sentiment: Strong Buy

  • Nothing but good news then and since then. Five months later the share price is lower than it was the day after BTD was announced.
    Any other biotech would be trading at $40 with CLDX's news by now.
    For some reason the market has it out for CLDX and won't let the share price rise to reflect its value.

    Marucci must deliver something of concrete, indisputable value to shareholders by the next CC.

  • Reply to

    Earnings

    by lennox64 Jul 31, 2015 12:17 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 1:37 PM Flag

    And now it's red-thumbing our posts in this thread. How doubly sad for that childish thing: lied and was caught ineptly trying to cover it up. How embarrassing for that pathetic lowlife. I hope you keep it on ignore. It's revealed its character today for all the world to see. It has no credibility whatsoever. Typical liberal. So typical.

  • Reply to

    Earnings

    by lennox64 Jul 31, 2015 12:17 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 1:24 PM Flag

    Rays,

    I found the deleted post using Google's cached pages archive:

    -----

    Reply to After speaking w/IR recently by raysfrom98 •Jul 22, 2015 4:19 PM
    .

    mybestbehavior • Jul 22, 2015 4:28 PM

    2
    users liked this posts

    users disliked this posts
    1
    Reply
    .

    Good stuff rays, thanks for sharing

    -----

    Yahoo won't let me post the link to the cached page, but you can find it without much difficulty by using words from mbb's post as your search terms as well as some terms from your thread's title. Then view Google's caches of the page.

    mbb caught in the act of lying and attempting to delete information to cover its tracks. Hmm... just like Hillary and Lois Lerner.

  • Reply to

    Earnings

    by lennox64 Jul 31, 2015 12:17 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 1:08 PM Flag

    Rays,

    After reading this post about mbb deleting his reply to you, I checked again and... the post I had just read literally only minutes ago is now gone, deleted, vanished.

    For all the world: mbb is a lying, conniving, immature, insecure dolt to whom no one should pay any attention. I've had him on ignore for over a year, and you should all ignore him too. But beware: if you put him on ignore and announce it mbb will seek "revenge" on you by childishly red-thumbing all of your future posts, as he does to mine even though he will probably deny that he does that; but he's been proven to be a liar now so no reason to trust anything he says about anything, including CLDX.

    Sentiment: Strong Buy

  • Reply to

    Earnings

    by lennox64 Jul 31, 2015 12:17 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 1:03 PM Flag

    Ha, Rays,

    Just this once I clicked on "show post" in your thread about earnings and the upcoming CC to see whether you were right about what mbb had posted and then lied about today. Yep: you are absolutely correct. What a lying, moronic POS that mbb is. He truly deserves to be on my ignore list!

    Sentiment: Strong Buy

  • Reply to

    Rintega rejection

    by dorriswelch Jul 30, 2015 6:55 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 12:44 PM Flag

    Rintega DOES work: statistically significant improvement in OS, PFS6 and every meaningful patient indication such as reduced need for steroids.

    Rintega WILL BE approved because it has been PROVEN to work.

    Sentiment: Strong Buy

  • Reply to

    Earnings

    by lennox64 Jul 31, 2015 12:17 PM
    whippersnapper65 whippersnapper65 Jul 31, 2015 12:25 PM Flag

    Rays informed us last week that IR had told him there will be a CC in August. Date TBA.

    Sentiment: Strong Buy

  • Celldex usually releases the PR announcing the CC one week ahead of the date of the CC.

    Last year the comparable CC was held on August 6.

    Marucci had better have a good surprise for investors in the week ahead and some concrete information about filing for accelerated approval for Rintega, because the way CLDX has been trading so weakly if the CC lacks specific, concrete, results-oriented information related to Rintega's accelerated approval then the market is going to murder the share price, as has often happened following CCs with no clear and meaningful guidance.

    Sentiment: Strong Buy

  • It would be a $35 stock fairly soon.

    This drop and recoup manipulation nonsense has got to stop.

    Time for gain and sustain to become the trading pattern.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Jul 28, 2015 8:59 PM Flag

    I remember. Rintega would probably be on the market right now if PFE hadn't withdrawn from its partnership with CLDX. Once Rintega receives approval, though, CLDX will be in a much better position for owning 100% of Rintega. AM wouldn't sell to PFE unless PFE overpaid. The article shows, however, that the big pharmas are desperately in search of the next big thing to solidify their earnings for the next two to three decades. CLDX is, in my opinion, one of the most valuable players in cancer immunotherapy; every big pharma has got to have CLDX on its short list of attractive acquisition candidates.

    Sentiment: Strong Buy

  • Pfizer Inc. Chief Executive Officer Ian Read said he’s on the hunt for an acquisition to build up the company’s collection of innovative drugs, five months after agreeing to a $17 billion deal to bolster the unit that sells older products.

    Read the rest of the article on Bloomberg. Yahoo also has a link to the story.

    My own comments:
    1. Biotech acquisitions will reach a fever pitch over the next two years.
    2. Immunotherapy is the hottest biotech sector for aggressive growth over that same period.
    3. Every major pharma is scouting out which small companies are likely to generate the next blockbusters.
    4. Celldex's treatments are poised to become highly valuable.
    5. Every big pharma will want to own Varli, not to mention the others.
    6. The Bloomberg article and the growing interest in biotech acquisitions of late are the tip of the iceberg.
    7. Celldex shareholders who hold and are patient will be amply rewarded.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Jul 28, 2015 4:46 PM Flag

    It's been unusually quiet, flog. The only "sign" that's been given has been the creation of the new Chief Commercial Officer position on the executive management team. In hindsight that will have been the tell. Of course, some of us can already read Marucci's signs. Of course, you don't create a position like that if Rintega is going to fail to get accelerated approval. Something big is coming, and it will come like a bolt out of the blue for those who haven't been paying attention, such as the 16 million shorts.

    Sentiment: Strong Buy

  • No: Planned Parenthood did.

    Yet the Left has a hissy fit about the flag. Black agitators rail against the flag.

    Priorities and perspective are two things the Left has skewed.

    In a Facebook status update, Palin posted a picture of the Confederate flag next to the Planned Parenthood logo, then asked, “Which symbol killed 90,000 black babies last year? #Defund Planned Parenthood.” By Monday, the post had garnered almost 111,000 likes and 59,000 shares.

  • The August CC will be one of the most important ever.

    Sentiment: Strong Buy

  • This one even more macabre than the prior two. PP is pure evil, and yes they have been selling fetal tissue for money. They videos prove it.

    Defund PP now!

    God bless the courageous and clever people who have exposed PP's evil profiteering off of murder and criminality.

  • whippersnapper65 whippersnapper65 Jul 27, 2015 11:04 PM Flag

    An institution also doesn't just decide to increase a holding in a single stock, much less a speculative biotech stock in a recent period of biotech sector weakness (with Grexit threatening to destabilize markets), by 280% to the tune of about $50M on a whim. Not only do they have analysts, they have sources and methods for obtaining anecdotal information by talking to doctors, patients and employees about what is really going on with the company. I bet NASDAQ will show CLDX institutional ownership at over 92% by the time all institutions have reported come August 14; it currently stands at just under 90%.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Jul 27, 2015 5:12 PM Flag

    Agree, J20. That's an enormous increase over their initial investment in the company.

    Institutions know CLDX is going to be the biotech success story of the decade, and they have been suppressing the share price to accumulate as many shares as they can before management begins releasing hit after hit after hit.

    CLDX is going to be the Pixar of biotech.

    Sentiment: Strong Buy

YHOO
36.69+0.02(+0.05%)Aug 3 4:00 PMEDT